Thursday, 2 May 2013

TCGA researchers identify potential drug targets, markers for leukemia risk; New study reveals relatively few mutations in AML genomes

Investigators for The Cancer Genome Atlas Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia, a deadly cancer of the blood and bone marrow. Their work paints a picture of a cancer marked by relatively few mutations compared to other types of cancer occurring in adults. Read more here.

Study mentioned: The Cancer Genome Atlas Research Network. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N Engl J Med. Online first May 1, 2013.

No comments:

Post a Comment